AMRI

AMRI Signs Exclusive Option to License its Tubulin Inhibitor Program for Cancer
CP Wire
Tue, 04/3/12 - 10:14 am
tubulin inhibitor
AMRI
AMRI Announces Collaboration Agreement with Lilly for In sourced Chemistry Services
CP Wire
Wed, 11/9/11 - 11:42 am
AMRI
Eli Lilly
in-sourcing
AMRI receiving $3M milestone payment from Bristol-Myers
Bizjournals.com
Wed, 05/25/11 - 11:32 am
milestone payments
AMRI
Bristol-Myers Squibb
CNS triple reuptake transporter inhibitors